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substantial. Thus, we sought to evaluate whether exercise cardiac reserve may be a more sensitive marker of cardiac toxicity than standard measures of cardiac function and if exercise training maintained cardiac function and exercise capacity during AC.
Methods:
28 BC patients undergoing AC were recruited into a non-randomised trial and allocated to exercise training (ET) (46.7±9.0 yrs, n = 14) or usual care (UC; 53.2±8.9 years, n = 14), respectively. Tests including echocardiography (left ventricular ejection fraction [LVEF] and global longitudinal strain [GLS] ), cardiopulmonary exercise test (peak oxygen uptake, VO peak), and exercise cardiac magnetic resonance imaging (exCMR, cardiac reserve) were performed prior to and after completion of AC. The ET group completed a twice weekly supervised aerobic and resistance exercise program at a moderate-vigorous intensity. 
Results:
There was a small statistically signi cant reduction resting in LVEF in both UC and ET, whereas GLS was unchanged (Table 1) . VO peak fell by 15% in the UC, while ET signi cantly attenuated the decline in tness (~4%). Cardiac reserve was reduced following AC (Visit×Exercise P= 0.05), which was not attenuated by exercise training (Visit×Exercise×Group P= 0.06). Exercise training had no e ect on resting measures of LV function (Table 1) . Clinical trial information: ACTRN12616001602415.
Conclusions:
AC treatment caused profound reductions in peak oxygen uptake and impaired cardiac reserve. Resting measures of cardiac function did not account for the large reduction in VO peak which was attenuated by exercise training.
E ect of AC and ET on resting measures of cardiac function, biomarkers and peak oxygen uptake. 
